Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian V Lee

Showing results (191-200 of 236) with videos related to

Pageof 24
Sort By:
Biorxiv : the Preprint Server for Biology|September 25, 2023
WCRC-25: A novel luminal Invasive Lobular Carcinoma cell line modelAshuvinee Elangovan, Emily A Bossart, Ahmed Basudan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2024
Spatial molecular profiling of mixed invasive ductal and lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutationsOsama Shiraz Shah, Azadeh Nasrazadani, Julia Foldi, et al.
Nature Communications|January 27, 2022
Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilitiesNicola Cosgrove, Damir Varešlija, Stephen Keelan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2025
Genomic and Immune Landscape of Pancreatic Ductal Adenocarcinoma Associated with Germline Pathogenic Variants in ATMSiddhartha Yadav, Riyue Bao, Rondell P Graham, et al.
The Lancet. Healthy Longevity|January 20, 2022
Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older womenNeil Carleton, Azadeh Nasrazadani, Kristine Gade, et al.
JAMA Surgery|July 17, 2024
Electronic Health Record-Based Nudge Intervention and Axillary Surgery in Older Women With Breast Cancer: A Nonrandomized Controlled TrialNeil Carleton, Thomas R Radomski, Danyang Li, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
Spatial molecular profiling of mixed invasive ductal-lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutationsOsama Shiraz Shah, Azadeh Nasrazadani, Julia Foldi, et al.
Redox Biology|August 26, 2023
Small molecule nitroalkenes inhibit RAD51-mediated homologous recombination and amplify triple-negative breast cancer cell killing by DNA-directed therapiesLisa Hong, Dennis C Braden, Yaoning Zhao, et al.
Cancer Research|December 21, 2017
The CARMA3-Bcl10-MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor-Positive Breast CancerPrasanna Ekambaram, Jia-Ying Lloyd Lee, Nathaniel E Hubel, et al.
Molecular Cancer Research : MCR|October 26, 2018
Frequent ESR1 and CDK Pathway Copy-Number Alterations in Metastatic Breast CancerAhmed Basudan, Nolan Priedigkeit, Ryan J Hartmaier, et al.
Pageof 24

Showing results (191-200 of 236) with videos related to

Sort By:
Pageof 24
Biorxiv : the Preprint Server for Biology|September 25, 2023
WCRC-25: A novel luminal Invasive Lobular Carcinoma cell line modelAshuvinee Elangovan, Emily A Bossart, Ahmed Basudan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2024
Spatial molecular profiling of mixed invasive ductal and lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutationsOsama Shiraz Shah, Azadeh Nasrazadani, Julia Foldi, et al.
Nature Communications|January 27, 2022
Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilitiesNicola Cosgrove, Damir Varešlija, Stephen Keelan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2025
Genomic and Immune Landscape of Pancreatic Ductal Adenocarcinoma Associated with Germline Pathogenic Variants in ATMSiddhartha Yadav, Riyue Bao, Rondell P Graham, et al.
The Lancet. Healthy Longevity|January 20, 2022
Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older womenNeil Carleton, Azadeh Nasrazadani, Kristine Gade, et al.
JAMA Surgery|July 17, 2024
Electronic Health Record-Based Nudge Intervention and Axillary Surgery in Older Women With Breast Cancer: A Nonrandomized Controlled TrialNeil Carleton, Thomas R Radomski, Danyang Li, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
Spatial molecular profiling of mixed invasive ductal-lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutationsOsama Shiraz Shah, Azadeh Nasrazadani, Julia Foldi, et al.
Redox Biology|August 26, 2023
Small molecule nitroalkenes inhibit RAD51-mediated homologous recombination and amplify triple-negative breast cancer cell killing by DNA-directed therapiesLisa Hong, Dennis C Braden, Yaoning Zhao, et al.
Cancer Research|December 21, 2017
The CARMA3-Bcl10-MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor-Positive Breast CancerPrasanna Ekambaram, Jia-Ying Lloyd Lee, Nathaniel E Hubel, et al.
Molecular Cancer Research : MCR|October 26, 2018
Frequent ESR1 and CDK Pathway Copy-Number Alterations in Metastatic Breast CancerAhmed Basudan, Nolan Priedigkeit, Ryan J Hartmaier, et al.
Pageof 24